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The pluripotent nature of human embryonic stem cells (hEsCs) makes them convenient for 
deriving therapeutically relevant cells. Here we show using Wnt reporter hEsC lines that the 
cells are heterogeneous with respect to endogenous Wnt signalling activity. moreover, the 
level of Wnt signalling activity in individual cells correlates with differences in clonogenic 
potential and lineage-specific differentiation propensity. The addition of Wnt protein or, 
conversely, a small-molecule Wnt inhibitor (IWP2) reduces heterogeneity, allowing stable 
expansion of Wnthigh or Wntlow hEsC populations, respectively. on differentiation, the Wnthigh 
hEsCs predominantly form endodermal and cardiac cells, whereas the Wntlow hEsCs generate 
primarily neuroectodermal cells. Thus, heterogeneity with respect to endogenous Wnt 
signalling underlies much of the inefficiency in directing hEsCs towards specific cell types. The 
relatively uniform differentiation potential of the Wnthigh and Wntlow hEsCs leads to faster and 
more efficient derivation of targeted cell types from these populations. 
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The pluripotent nature of human embryonic stem cells (hESCs) makes them a convenient in vitro model for studying aspects of early development and a common starting point 
for deriving numerous therapeutically relevant cells. Although it 
is often assumed that hESCs exist as a homogenous population of 
pluripotent cells, recent studies suggest hESC cultures contain sig-
nificant heterogeneity. For example, SSEA-3 expression level distin-
guishes two populations of undifferentiated hESCs with different 
proliferation rates, clonogenic potential and OCT4 protein levels1. 
Even among hESCs with uniformly high OCT4, Nanog and SSEA-
3 expression, distinct subpopulations with lineage-specific epiblast 
stem cells surface markers and differentiation propensities have 
been found2. Similar heterogeneity is found in mouse embryonic 
stem cells3 and epiblast stem cells (EpiSCs)4. In all of these cases, 
clonally isolated subpopulations rapidly re-establish the other pop-
ulations, suggesting efficient maintenance of equilibrium among the 
different subpopulations. This persistent heterogeneity within hESC 
cultures makes it difficult to rigorously establish the roles of spe-
cific signalling molecules, and this may underlie the poor efficiency 
of directed differentiation towards specific cell types5,6. Thus, the 
ability to stably maintain homogenous populations of pluripotent 
hESCs would greatly improve their utility. Wnt signalling has been 
widely implicated in hESC biology, but there is disagreement about 
whether Wnt signalling promotes self-renewal or differentiation7–13. 
Here we used Wnt reporter hESC lines, to establish that the cells are 
heterogeneous with respect to endogenous Wnt signalling activity. 
By manipulating Wnt signals, we reduced heterogeneity leading to a 
more efficient derivation of targeted cell types from hESCs.
Results
Wnt reporter hESC lines are heterogeneous. To monitor Wnt 
pathway activity in living cells, we generated clonal H9 hESC lines 
carrying a stably integrated TCF-GFP reporter14 (Fig. 1a). We 
observed a range of TCF-GFP expression patterns, from colonies 
with no detectable expression to colonies with expression in cells 
at the periphery and expression throughout. Stimulating Wnt 
signalling with purified Wnt3a protein or CHIR99021, a small-
molecule GSK3β-inhibitor, resulted in uniformly high green 
fluorescent protein (GFP) expression (Fig. 1b). Conversely, inhibiting 
endogenous Wnt signalling with IWP2-lowered GFP expression 
(Fig. 1b), confirming the fidelity of our reporter lines. Our ability 
to detect endogenous Wnt pathway activity in hESCs differs from 
previous reports using transient transfections8,9, reflecting the 
importance of using genomically integrated, non-silenced, reporters.
hESCs with various levels of Wnt activity differed from each 
other in several respects. We measured the self-renewal potential of 
individual Wnthigh or Wntlow cells using a quantitative clonogenic 
potential assay1,2. hESCs were sorted into populations of greater 
than 99.5% pure Wnthigh or Wntlow hESCs using two rounds of flu-
orescence-activated cell sorting (FACS; Supplementary Fig. S1A). 
Wnthigh single cells formed more than five times as many alkaline 
phosphatase (AP)-positive and OCT4-positive pluripotent colo-
nies as Wntlow cells (Fig. 1c), despite similar expression of OCT4, 
SSEA-4 and TRA-1-60 in both starting populations (Supplementary 
Fig. S1B–D). By measuring gene expression in  > 99.5% pure popu-
lations, we found that Wnthigh hESCs expressed more than tenfold 
higher levels of primitive streak/mesoderm markers Brachyury, 
Mixl1 and Goosecoid, as well as fourfold higher levels of endoder-
mal markers CXCR4 and Sox17 relative to Wntlow hESCs (Fig. 1d). 
In contrast, the neuroectodermal marker Pax6 was higher in 
Wntlow hESCs. Markers of extra-embryonic endoderm (SOX7) 
and trophectoderm (CGA) were unchanged or undetectable in 
either population. Thus, even among cells with similar expres-
sion of pluripotency markers, hESCs are heterogeneous, and cells 
with different clonogenic potential and epigenetic status can be 
prospectively identified by monitoring Wnt pathway activity.
The enhanced clonogenic potential of Wnthigh hESCs did not 
correlate with elevated expression of pluripotency markers; there-
fore, we tested whether Wnt signalling could also affect prolifera-
tion or survival of hESCs. We found only a very small difference 
in the percentage of proliferating cells in the Wnthigh population of 
pluripotent cells compared with Wntlow pluripotent cells (Fig. 2a,b). 
Likewise, addition of purified Wnt3a to hESCs did not significantly 
alter the proliferation of pluripotent cells (Fig. 2c). More signifi-
cantly, we found that Wnt signalling promoted survival of hESCs. 
When the number of viable hESCs was counted one day after pas-
sage as single cells, cultures treated with purified Wnt3a protein for 
24 h before passage contained 20% more viable cells (Fig. 2d). This 
effect is likely due to Wnt-mediated inhibition of apoptosis, as over-
expression of the apoptosis inhibitor BCL-2 phenocopied the effect 
of Wnt signalling on hESC clonogenicity (Fig. 2e). BCL-2 overex-
pression was largely epistatic to addition of Wnt protein, supporting 
the interpretation that Wnt promotes survival of hESCs by inhibit-
ing apoptosis. These data explain how Wnt signalling can simulta-
neously enhance clonogenicity of hESCs, even though pluripotency 
markers are not affected and expression of differentiation markers is 
moderately increased.
When the sorted populations of Wntlow and Wnthigh cells 
were plated in self-renewing conditions, the heterogeneity was 
re-established within a single passage (Fig. 1e,f). We also initiated 
new cultures from single colonies that were homogenously GFP 
negative (Wntlow colonies) or homogenously GFP positive (Wnthigh 
colonies). All of the colonies picked (9/9 GFPlow and 6/6 GFPhigh) 
re-established new cultures that contained each of the three col-
ony types shown in Fig. 1a, and FACS analysis showed that all of 
the clonal cultures now contained a mixture of Wntlow and Wnthigh 
cells (Fig. 1g).
Culture conditions influence Wnt effects on cells. The rapid re-
establishment of heterogenous cultures prompted us to attempt to 
derive more stable homogenous populations by including purified 
Wnt3a protein or IWP2 in the cultures. Although these experi-
ments were successful, we found that the phenotype of Wnthigh 
hESCs depended on the conditions, in particular, the medium 
used for cell growth. To more fully understand how growth media 
altered the Wnt phenotypes, we used three different hESC culture 
systems. In addition to the ‘Standard hESC’ conditions used above 
(feeder cells + serum replacement), we used two defined culture 
media, N2B27 and mTeSR1, both of which use Matrigel in lieu of 
feeder cells15,16. In all media, Wnt3a protein, IWP2 and CHIR99021 
induced the expected changes in TCF-GFP reporter expression 
(Supplementary Fig. S2A,B), except that CHIR99021 was less 
effective in mTeSR1.
In terms of effects on hESC behaviour, Wnt signalling influ-
enced cells differently in defined media compared with standard 
hESC medium. Wnt3a enhanced self-renewal in standard hESC 
conditions, as indicated by faster accumulation of AP-positive 
colonies in Wnt3a-treated conditions relative to control buffer 
(Veh), similar to previous observations12. However, Wnt protein 
caused rapid differentiation in both N2B27 and mTeSR1 (Fig. 3a,b). 
The loss of pluripotent colonies in defined media was accompa-
nied by an increase in total cell number, suggesting that the cells 
differentiated rather than died (Fig. 3c). Differentiation was con-
firmed by loss of OCT4 expression and gain of Brachyury and 
GATA4 expression in defined media (Fig. 3d). The Wnt inhibitor 
IWP2 modestly reduced the number of AP +  colonies, roughly 
proportional to total cell number on standard hESC media, but 
had little effect in defined media on the number of AP +  colonies 
or OCT4 staining (Supplementary Fig. S2C–F). The overall cell 
number was reduced after three passages in N2B27 media, possibly 
due to IWP2 inhibiting secretion of other Wnt proteins required 
for optimal proliferation on this media (Supplementary Fig. S2F). 
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Overall, Wnt signalling promoted expansion of undifferentiated 
hESCs in standard medium and rapid differentiation of hESCs in 
defined media.
Influence of lysophosphatidic acid (LPA) in serum replacement 
medium. To identify the factor(s) responsible for conferring dif-
ferent Wnt signalling activities in various media, we screened for 
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Figure 1 | Endogenous Wnt signalling reveals distinct subpopulations of hESCs. Analysis of transgenic 7xTCF-GFP hEsCs in standard self-renewing 
conditions. (a) TCF-GFP expression pattern in live hEsC colonies. scale bar, 200 µm. (b) FACs analysis of TCF-GFP expression in live cells after  
4 days of IWP2, Wnt3a or CHIR99021 treatment. Pre-gated for live, non-mouse cells. (c) Quantitative Clonogenic Potential Assay. Double FACs-sorted 
populations of TCF-GFPhigh and TCF-GFPlow cells were plated as single cells in standard hEsC. Clonogenic potential was determined by counting the 
number of alkaline phosphatase (AP)-positive (left) and oCT4-positive (right) colonies 7 days after plating. Error bars show the range of two biological 
replicates and are representative of three independent experiments. (d) Gene expression analysis in double FACs-sorted populations of  > 99.5% purity. 
The ratio of glyceraldehyde 3-phosphate dehydrogenase-normalized gene expression level in TCF-GFPhigh hEsCs divided by TCF-GFPlow hEsCs is  
shown. nD, not detectable.  ± s.d of three biological replicates and are representative of two independent experiments. (e) GFP expression pattern of 
live colonies derived from plating single cells of  > 99.5% pure populations at clonal density (500 cells per cm2) in standard self-renewing conditions. 
The starting populations are indicated on the x axis, examples of the three GFP expression patterns counted are shown in a. (f) FACs analysis of GFP 
expression in hEsC cultures 9 days after plating single cells from the indicated population of sorted cells. %GFPpos is based on live, non-mouse cells.  
(g) FACs analysis of GFP expression in hEsC passage 2 cultures initiated from single colonies that were entirely GFPlow or GFPhigh. %GFPpos is based  
on live, non-mouse cells.
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components of standard hESC medium that could prevent Wnt-
mediated differentiation in defined conditions. We found that 
adding knockout serum replacement (KOSR) to N2B27 or mTeSR1 
media efficiently blocked the Wnt-mediated differentiation (Fig. 3e 
and Supplementary Fig. S3A). Conversely, reducing the concentra-
tion of KOSR in standard hESC conditions from 20 to 2% allowed 
Wnt3a-mediated differentiation (Fig. 3f), showing KOSR was the 
key difference between culture systems. In agreement, KOSR addi-
tion to N2B27 allowed expansion of hESCs colonies in the presence 
of Wnt3a for three passages (Supplementary Fig. S3B), it prevented 
loss of OCT4 protein expression on Wnt addition to either N2B27 
(Supplementary Fig. S3C) or mTeSR1 media (Supplementary 
Fig. S3D), and it prevented the gene expression changes associated 
with Wnt3a-mediated differentiation on N2B27 media (Fig. 3h). 
Importantly, KOSR did not affect the ability of Wnt3a to activate 
the TCF-GFP reporter (Fig. 3g and Supplementary Fig. S3C,D), 
showing that KOSR did not interfere with Wnt signal transduction, 
rather KOSR blocked the loss of pluripotency otherwise caused by 
Wnt signalling in defined media.
Even though hESCs treated with Wnt plus KOSR exhibited 
pluripotency, they also expressed elevated levels of Brachyury and 
Mixl1 mRNA, two well-established markers of primitive streak cells 
(Fig. 3i). Co-staining of OCT4 and Brachyury showed that Brachy-
ury was broadly upregulated throughout the OCT4-positive cells in 
Wnt3a-treated colonies (Supplementary Fig. S4). Furthermore, the 
co-expression of primitive streak markers and pluripotency mark-
ers in Wnt3a-treated hESCs was not due to slow or delayed differen-
tiation as these cells could be expanded for more than ten passages 
in the presence of Wnt3a and KOSR, maintaining high expression 
of pluripotency markers indefinitely (Supplementary Fig. S5A–D). 
Likewise, hESCs treated with IWP2 could also be expanded for more 
than ten passages while retaining equally high levels of pluripotency 
markers and reduction of primitive streak markers. Therefore, in the 
presence of KOSR, Wnt signalling does not significantly enhance 
or reduce expression of pluripotency markers, but it does induce 
expression of primitive streak markers in undifferentiated cells.
KOSR is a partially defined supplement used to replace serum 
in a variety of cell culture applications. To determine which 
component(s) of KOSR were responsible for blocking hESC differ-
entiation, we separated the ingredients of KOSR by size using a series 
of molecular-weight cutoff filters. We tested each fraction for the 
ability to prevent Wnt-mediated morphological changes. The active 
component was found to reside in the 50–100 kDa fraction (Fig. 4a). 
The only ingredient in this fraction that was not also found in either 
N2B27 or mTeSR1 media was a lipid-rich BSA supplement called 
AlbuMaxII. AlbuMaxII is present at about 1.6% (w/v) in standard 
hESC culture conditions, and was able to fully substitute for KOSR 
at this concentration (Fig. 4b). As BSA is already present in N2B27 
at 500 µg ml − 1, and further supplementation with lipid-free BSA up 
to 1 mg ml − 1 was not able to substitute for AlbuMaxII, we suspected 
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Figure 2 | Role of Wnt signalling in proliferation and survival. (a) FACs analysis of TCF-GFP hEsCs grown in standard hEsC conditions showing the 
number of proliferating (Edu-positive) cells in log-phase cultures (boxed cells). Cells were pre-gated for oCT4-positive non-mouse cells single cells, 
and separated into either TCFlow (left panel) or TCFhigh (right panel) populations. (b) The percentage of proliferating oCT4-positive cells in TCFlow and 
TCFhigh populations in a was averaged across two independent experiments ± range. (c) The percentage of proliferating oCT4-positive hEsCs after  
3 days of treatment with Wnt3a or vehicle was measured as in a and b. The average from two independent experiments is shown. (d) Log-phase hEsCs 
were treated with IWP2 or Wnt3a for 24 h, digested to single cells, counted and plated at 200,000 cells per cm2. The number of viable attached cells 
still present 24 h after passage was measured. The average number of cells in four replicates of two independent experiments is shown. The P-value is 
calculated from a two-tailed equal variance T-test. (e) Identical numbers of H9 or H9-BCL2 hEsCs were plated in standard hEsC media on matrigel in  
the presence of dimethyl sulfoxide (Dmso; control for IWP2), IWP2, vehicle (control for Wnt3a) or Wnt3a. The number of AP-positive colonies was 
counted 6 days later. The average of three replicates in a single experiment are shown,  ± s.d.
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Figure 3 | Serum replacement blocks Wnt-mediated differentiation. (a) Alkaline phosphatase (AP) staining of cells grown in ‘standard (std)’, ‘n2B27’ 
and ‘mTesR1’ media for three passages in the continuous presence of Wnt3a protein or control buffer (vehicle). scale bar, 2 mm. (b) Quantification 
of Wnt-mediated changes in self-renewal during passage as clumps. The number of AP +  colonies was determined after each passage. The ratio of 
cumulative number of AP +  colonies in Wnt3a-treated cultures divided by AP +  colonies in vehicle-treated cultures is shown for each passage in each 
media. 100% represents an equal number of AP +  colonies in Wnt3a- and vehicle (Veh)-treated cultures. The average  ± s.d. of three biological replicates 
is shown, and is representative of two independent experiments. (c) Quantification of Wnt-mediated changes in total cell number during passage as 
clumps. The ratio of cumulative cell number in Wnt3a-treated cultures divided vehicle-treated cultures is shown on a log scale. The average  ± s.d. 
of three biological replicates is shown, and is representative of two independent experiments. (d) Phase-contrast and oCT4, Brachyury and GATA4 
immunofluorescence images of cells treated with Wnt3a for 7 days in standard hEsC media, n2B27 or mTesR1. scale bar, 200 µm. (e) Phase-contrast 
images of hEsCs treated for 4 days with Wnt3a in n2B27 media alone, or the same supplemented with 20% PBs or 20% knockout serum replacement 
(KosR). scale bar, 200 µm. (f) AP staining of hEsC treated for 3 days with Wnt3a in standard hEsC media, or the same media in which the KosR 
concentration was reduced to 2%. scale bar, 200 µm. (g) Phase contrast and GFP fluorescence in live colonies after 5 days of growth on n2B27 in the 
presence of vehicle, 20% PBs or 20% KosR. scale bar, 200 µm. (h,i) Gene expression analysis in cells grown in n2B27 plus the indicated combination 
of vehicle, Wnt3a and KosR for four passages. Values were normalized to glyceraldehyde 3-phosphate dehydrogenase, and are expressed relative to 
vehicle-treated cells at passage 1. The average and range of two biological replicates is shown.
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that the active ingredient was one of the lipids associated with BSA. 
LPA is one of the lipids known to be associated with BSA in serum, 
and has been implicated in hESC biology previously17. Indeed, we 
found that 10 µM LPA could substitute for 20% KOSR in prevent-
ing Wnt3a-mediated differentiation hESCs in defined conditions 
(Fig. 4b). As with KOSR, neither AlbuMaxII nor LPA affected the 
ability of Wnt3a to activate Wnt signalling in hESCs (Fig. 4b,c).
Despite the ability of LPA to block Wnt-mediated differentia-
tion in hESCs, we could not maintain undifferentiated hESCs on 
defined media (N2B27 media + Matrigel) in the presence of LPA for 
more than two or three passages, regardless of whether Wnt3a was 
present or not. However, hESCs could also be expanded in N2B27 
media when mouse embryonic fibroblast (MEF) feeders cells were 
used in lieu of Matrigel, and we found that Wnt3a also induced 
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differentiation of hESCs under these conditions, albeit slower than 
in media lacking feeders (Fig. 4d compare with Fig. 3a). Addi-
tion of either 1 or 10 µM LPA resulted in a dose-dependent block 
in Wnt3a-mediated differentiation, allowing normal expansion of 
AP +  hESCs in the presence of Wnt3a for three passages (Fig. 4e–g). 
LPA is a lipid-signalling molecule with known roles in early devel-
opment (for review see refs 17–20) It is known to signal through 
at least seven different G-protein-coupled receptors. We found that 
Ki16425, an inhibitor of signalling through LPA receptors 1 and 2 
(ref. 21), did not abrogate the affects of LPA, suggesting hESCs use 
one of the other receptors. Taken together, these data uncover a role 
for lipids in hESC biology.
Differentiation of Wnthigh and Wntlow cells. During gastrula-
tion, cells that enter the primitive streak form the mesodermal and 
endodermal germ layers, whereas neuroectodermal cells are formed 
from cells outside the primitive streak22. Wnt signalling is highly 
active in the primitive streak23–25, therefore, we asked whether 
the level of Wnt signalling in undifferentiated hESCs would affect 
their differentiation potential when self-renewal conditions were 
removed. The lower expression of primitive streak markers in the 
Wntlow TCF-GFP hESCs (Fig. 1d) and in IWP2-treated non-trans-
genic hESCs (Supplementary Fig. S6) suggested that these cells had 
neuroectodermal potential. We directed the differentiation of hESC 
towards the neural lineage by omitting FGF2 and adding Noggin 
and SB431542 (ref. 26). IWP2-treated cells formed more Pax6 + 
and Otx2 +  neuroectodermal cells than untreated hESCs or Wnt3a-
treated hESCs (Fig. 5a,b). In fact, hESCs maintained on N2B27 plus 
Wnt3a and KOSR did not form a single Pax6-positive cell in this 
assay, indicating that Wnt3a imparts a very strong block in neur-
oectodermal differentiation in vitro. Consistently, when TCF-GFP 
hESCs grown in standard hESC conditions were sorted into Wntlow 
and Wnthigh populations and subjected to the neural differentia-
tion protocol, Wntlow cells formed more than 25-fold more Pax6 +  
neuroectodermal cells than Wnthigh cells (Fig. 5c). These data sug-
gest a model in which elevated Wnt signalling in the presence of 
KOSR traps hESCs in a primitive streak-like state from which they 
cannot differentiate into neuroectodermal cells.
If Wnt signalling confers primitive streak characteristics to 
hESCs, then Wnthigh cells should have an advantage in endoder-
mal and mesodermal differentiation. Indeed, Wnt3a-treated hESCs 
differentiated into endodermal cells far more efficiently than IWP2-
treated hESCs in two different assays. First, instead of forming 
neuroectodermal cells on addition of Noggin and SB431542, 
Wnt3a-treated cells readily formed FOXA2-positive endodermal 
cells (Fig. 5d), whereas IWP2-treated cells did not. Second, when 
BMP4 and Activin A were used to direct differentiation towards 
primitive streak derivatives27, Wnt3a-treated hESCs formed more 
GATA4 +  cells with higher average GATA4 expression than either 
the untreated or IWP2-treated hESCs (Fig. 5e). IWP2-treated 
hESCs formed few GATA4 +  cells, all of which had lower average 
GATA4 expression than the other populations. These data dem-
onstrate the enhanced endodermal differentiation propensity of 
Wnthigh hESCs.
In addition, we tested for mesodermal differentiation poten-
tial by comparing the ability of IWP2- or Wnt3a-treated hESCs 
to differentiate into beating cardiomyocytes. We used a four-stage 
protocol28 in which pluripotent hESCs are induced to form beating 
cardiomyoctes over the course of 2 weeks (Fig. 5f). We subjected 
IWP2-treated, Wnt3a-treated and untreated hESCs to the full pro-
tocol, as well as a series of shortened protocols to determine whether 
starting with Wnthigh cells could shorten the time it takes to derive 
cardiomyocytes. Cardiac differentiation was scored by counting 
the number of beating sectors present on day 15 of the full-length 
protocol. When starting from untreated hESCs, we found that 
the full-length protocol resulted in the highest number of beating 
sectors, as expected (Fig. 5g). Wnt3a-treated hESCs on the other 
hand formed the most beating sectors when the first two stages 
of differentiation were eliminated entirely. In fact, Wnt3a-treated 
hESCs subjected to only the last two stages of differentiation formed 
more beating sectors than untreated hESCs given the full-length 
protocol. Thus, using Wnt3a and KOSR to maintain hESCs resulted 
in faster, more efficient-directed differentiation into cardiomyocytes 
and endodermal cells. Wntlow hESCs formed few beating sectors 
regardless of protocol length, consistent with their neuroectodermal-
specific differentiation propensity. Therefore, by including IWP2 or 
Wnt3a + KOSR in the self-renewal medium, hESCs can be expanded 
indefinitely in a state that allows faster and more efficient differen-
tiation towards neuroectodermal or mesodermal/endodermal cell 
types, respectively.
Finally, given the strong differentiation biases of Wntlow and 
Wnthigh hESCs, we questioned whether these cells were still pluripo-
tent. Strong expression of pluripotency markers in both popula-
tions (Supplementary Fig. S5A–D) suggested this was the case, 
but teratoma formation is the best measure of pluripotency in 
hESCs. Therefore, we injected Wnthigh hESCs under the kidney 
capsule of nude mice and examined the resulting tumours 8 weeks 
later. We found evidence of differentiation into all three germ lay-
ers in every tumour (Fig. 5h–m), showing these cells remained 
pluripotent even after five passages in the presence of Wnt3a and 
KOSR media. In agreement, removal of Wnt3a or IWP2 from any 
culture resulted in re-establishment of heterogeneous TCF-GFP 
expression levels within three passages. Thus, both the level of Wnt 
signalling (Fig. 1e,f) and the lineage-specific differentiation biases 
of hESCs (Fig. 5h–m) are reversible phenotypes. In hESCs cultured 
under standard conditions, this reversibility leads to a dynamic 
equilibrium of individual hESCs with distinct differentiation biases, 
thereby limiting the efficiency with which any single lineage can be 
targeted.
Discussion
Our data show that different levels of Wnt signalling confer distinct 
lineage-specific differentiation propensities to hESCs. Wntlow/IWP-
treated cells are maintained as pluripotent cells, and show enhanced 
ability to differentiate into neural cells on inhibition of transforming 
growth factor-β signalling. Wnt-treated hESCs, on the other hand, 
acquire primitive streak-like characteristics and, in defined self-
renewal media, rapidly differentiate into mesodermal and endo-
dermal cells. In the presence of KOSR, however, Wnt still drives 
hESCs towards a primitive streak-like state, but differentiation is 
blocked before loss of pluripotency. hESCs in this fluid pluripotent/
primitive streak-like state can be expanded indefinitely, and can 
differentiate into mesodermal and endodermal cells with greater 
speed and efficiency than heterogeneous populations. The ability 
of KOSR to block Wnt-mediated loss of pluripotency and enhance 
clonogenicity reconciles many of the discrepancies among reports 
using different self-renewal media to assess the role of Wnt signal-
ling in hESCs7–13. Further discrepancies have arisen from the fact 
that Wnt signalling simultaneously increases self-renewal (Fig. 3a,b) 
and traditional markers of differentiation (Fig. 3i) when added to 
hESCs in the presence of KOSR. Finally, it is worth noting that the 
role for Wnt3a in hESCs identified herein is significantly different 
from the role that we and others have shown for Wnt3a in mouse 
ESCs14,29–31. In the latter case, Wnt3a blocked developmental pro-
gression from the naive mESC state14 to the primed EpiSC state; 
whereas the primary role of Wnt in hESCs is to drive differentiation 
out of the pluripotent primed state of hESCs and into differentiated 
mesodermal and endodermal cells.
Methods
Cell culture. Routine culture of H9 hESCs was performed on a feeder layer of irra-
diated CF1α MEFs at 20,000 cells per cm2 in ‘standard hESC media’ (DMEM/F12, 
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Figure 5 | Distinct lineage-specific differentiation propensities of Wntlow and Wnthigh hESCs. (a,b) hEsCs maintained with various levels of Wnt 
pathway activation were subjected to the neural differentiation protocol for 5 days. neuralectodermal differentiation was detected by immunostaining 
for Pax6 (a) and otx2 (b). scale bar, 200 µm. (c) FACs-sorted populations of  > 95% pure TCF-GFPhigh or TCF-GFPlow were subjected to the neural 
differentiation protocol for 5 days. neural differentiation was detected by PAX6 staining, and compared with the number of DAPI-positive nuclei using 
an automated counting algorithm. Average  ± s.d. from five fields of view, representing three independent experiments. (d) Immunofluorescent staining 
for endodermal marker FoxA2 in hEsCs subjected to the neural differentiation protocol for 5 days. scale bar, 200 µm. (e) Immunofluorescent staining for 
endodermal marker Gata4 on day 5 of the endodermal differentiation protocol. scale bar, 200 µm. (f) schematic description of cardiogenic differentiation 
protocol. (g) IWP2- and Wnt3a-treated hEsCs in standard hEsC media were subjected to the cardiogenic differentiation protocol, and shortened versions 
thereof. The number of spontaneously beating sectors observed on days 15–18 of the full-length protocol (days 12–15 of the shortest protocol) were 
averaged. Error bars  ± s.d., n = 4. (h–m) Hematoxylin and eosin staining of tumours arising 8 weeks after injecting hEsCs maintained in n2B27 with Wnt3a 
and KosR for five passages under the kidney capsule of nude mice. (h) neural rosette, (i) pigmented epithelium, (j,k) glandular structures, (l) cartilage 
and (m) bone. scale bar, 50 µm.
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20% KOSR (Invitrogen), 10 ng ml − 1 basicFGF (Peprotech), 1% MEM non- 
essential amino acids, 0.1 mM β-mercaptoethanol and 1 mM glutamine). Cells 
were passed as clumps following 30 min digestion with 1 mg ml − 1 collagenase IV, 
every 4–6 days. Cells cultured in N2B27-CDM14 or mTeSR1 (Stemcell Technolo-
gies) were grown on Matrigel (BD Biosciences)-coated tissue culture plastic instead 
of MEFs, and passed as clumps using 1 mg ml − 1 dispase instead of collagenase 
IV. Recombinant mouse Wnt3a was produced in Drosophila S2 cells grown in 
suspension culture, and purified by affinity and gel filtration chromatography as 
described32. Wnt3a protein was used at 100 µg ml − 1, IWP2 (Stemgent) at 2 µM, 
and CHIR99021 (Stemgent) at 3 µM. All reagents were changed daily in all  
experiments herein, except during the cardiac differentiation protocol.
Generation of transgenic Wnt reporter hESCs. Three independent monoclonal 
transgenic Wnt reporter lines were generated by transducing three separate pools 
of hESCs with a lentivirus harbouring a 7xTCF-eGFP construct and puromycin 
resistance gene14. Transduced pools were selected with puromycin 4 days after 
transduction, cultured separately for 2 weeks to allow viral silencing to proceed 
and then plated as single cells in standard hESC conditions in the presence of 
ROCK inhibitor Y27632 (ref. 33) to allow clonal outgrowth. After 5 days of clonal 
outgrowth, Wnt3a was added for 24 h and one Wnt-responsive colony from each 
pool was selected for expansion and experimentation.
Quantitative clonogenic potential assay. hESCs were digested to single cells  
using Accutase, FACS sorted in some cases, counted and plated at 500–2,500 cells 
per cm2 in ‘standard hESC media’1,2. AP activity was detected 7 days later using  
the SCR004 kit (Millipore). In some cases, colonies were fixed and stained for 
OCT4 to get an independent measurement of clonogenic potential. For experi-
ments using multiple passages, duplicate wells were grown, one of which was used 
for clonogenic potential assay, the other being used for passage. AP +  colonies 
were counted by hand using a dissecting microscope. These experiments were 
performed in duplicate (TCF-GFPhigh versus TCF-GFPlow), triplicate (Wnt3a  
and CHIR99021 on all media) or quadruplicate (IWP2 on all media).
Directed differentiation protocols. Differentiation of hESC towards endoderm 
was accomplished using stage one of the protocol described in ref. 27. hESC  
were treated with Y-27632 for 1 h before digesting to single cells using Accutase 
(Stemgent). Single cells were plated at 50,000 cells per cm2 in N2B27 media  
supplemented with 10 µM Y-27632. Twenty-four hours later, media were changed 
to StemPro-34 (Invitrogen), 2 mM glutamine, 0.4 mM monothioglycerol, 
50 µg ml − 1 ascorbic acid, 3 ng ml − 1 Activin A (R&D Systems), 10 ng ml − 1 BMP4 
(R&D Systems) and 5 ng ml − 1 FGF2 (Peprotech). Differentiating cells were fixed 
and stained for 4′,6-diamidino-2-phenylindole (DAPI) and GATA4 after 4 days  
of differentiation.
Differentiation of hESC towards neuroectoderm used the protocol described 
in ref. 26. Briefly, hESCs pretreated with Y-27632 for 1 h were digested to single 
cells with Accutase. Single cells were plated at 60,000 cells per cm2 in N2B27 media 
supplemented with 10 µM Y-27632. Twenty-four hours later, media was changed 
to SN media (similar to standard hESC media, except lacking FGF2 and containing 
with 50 ng ml − 1 human recombinant Noggin (R&D Systems) and 10 µM SB431542 
(Stemgent)). Cells were fixed and stained for DAPI, Pax6, Otx2 and FoxA2 after  
5 days in SN media.
Cardiogenic differentiation was induced following the protocol reported in  
refs 27,28. Approximately 1×106 hESCs of each population were digested into 
clumps of 100–200 cells using collagenase IV and slight trituration. hESC clumps 
were washed and resuspended in mTeSR1 media, and plated at 200,000 cells per 
well in ultra-low-adherence six-well plates. Cardiovascular differentiation was initi-
ated the following day (day 0) by changing the base media to StemPro-34 supple-
mented with 2 mM glutamine, 0.4 mM monothioglycerol and 50 µg ml − 1 ascorbic 
acid. The base media was supplemented with the cytokines: 50 ng ml − 1 Wnt3a for 
day 0–1; 20 ng ml − 1 each BMP4, VEGF and Activin A for days 1–3; 50 ng ml − 1 
soluble Frizzled-8 CRD34 plus 10 ng ml − 1 VEGF for days 3–5; 50 ng ml − 1 each 
FGF8 and Wnt11 for days 5–9, 9–13 and 13–17. To determine whether Wnthigh 
hESCs had any cardiovascular differentiation advantages, separate pools of hESC 
aggregates were subjected to this protocol beginning on Day 0, 1, 2 or 3. Beating 
sectors were counted in each condition on protocol days 14–16 and averaged.
Immunohistochemistry. Cells were fixed in 4% paraformaldehyde for 15 min, 
washed twice with PBS/0.5% Triton X-100 (PBT), permeabilized for 10 min with 
0.1% Tween-20 in PBS, and blocked with 5% normal donkey serum or 10% BSA 
for 1 h. Cells were incubated with primary antibody (see below) diluted in blocking 
buffer overnight at 4 °C, washed three times with PBT, incubated with species- 
specific secondary antibodies conjugated to Alexa488 or Cy3 for 1 h at room  
temperature (Jackson ImmunoResearch), washed three times with PBT, and  
imaged on an Axiovert 200 inverted microscope with an Axiocam HRc camera 
(Carl Zeiss). Images were analysed using AxioVision 4.8.2 software (Zeiss).
Fluorescence-activated cell sorting. hESC colonies were dissociated to single 
cells with Accutase, pelleted and resuspended in PBS/10% serum for staining with 
antibodies (see below). Rat anti-mouse CD29-APC (BioLegend, 1:200) was used 
identify and exclude mouse feeder cells, propidium iodide (3 µg ml − 1) was used 
to identify and exclude dead cells. Cells were analysed and sorted on a FACSAria 
II cell sorter (BD Biosciences). FACS data were analysed with the FlowJo software 
(TreeStar). GFP gates were set based on differences in the GFP expression profile of 
IWP2-Wnt3a-treated hESCs, other gates were set based on florescence minus one 
control samples, which lacked the primary antibody of interest, but contained all 
other antibodies and stains. For clonogenic and GFP reversion analyses, cells were 
pretreated with 10 µM Y-27632 for 1 h before digestion.
Cell proliferation was measured using the Click-iT Edu Cell Proliferation Assay 
for Flow Cytometry (Invitrogen). hESCs in log-phase growth were pulsed with  
Edu for 3 h before processing. Data are shown only for OCT4-positive cells for  
two reasons: to avoid obscuring the role of Wnt in undifferentiated cells by  
including differentiating cells in the analysis and to allow elimination of mouse 
feeder cells from the analysis without needing to stain for CD29.
Antibodies and flow cytometry. Antibodies were used at the following concentra-
tions: Oct4 (Santa Cruz Biotechnology, 1:100), Nanog-PE (BD Pharmingen, 1 test 
per ml), SSEA3-Alexa488 (eBiosciences, 1 test per ml), SSEA4-PE (R&D Systems, 
0.5 test per ml), TRA160-FITC (Biolegend, 1:100), Pax6 (Covance, 1:2,000), Otx2 
(Abcam, 1:2,000), FoxA2/HNF3β (Santa Cruz Biotechnology, 1:250), GATA4- 
Biotin (R&D Systems, 1:50), Brachyury-Bio (R&D Systems, 1:50) and GFP  
(Abcam, 1:1,000).
Gene expression analysis. Total RNA was prepared using a QIAGEN RNeasy 
mini kit with on-column DNase digestion, followed by random hexamer-primed 
reverse transcription using Superscript III RT-PCR kit (Invitrogen). Quantitative 
real-time PCR was performed on a StepOne Plus (Applied Biosystems) using a 
SYBR green technology. Standard curves were performed for each gene in every 
run, and all PCR reactions were performed for three independent experiments 
with two technical replicates in each experiment. Glyceraldehyde 3-phosphate 
dehydrogenase was used to normalize all samples for starting material. Primer  
sequences were designed using Lightcycler Probe Design Software 2.0 (Roche) 
such that they spanned splice junctions when possible (Supplementary Table S1).
Kidney capsule transplantation and teratoma analysis. A total of 1×106 hESCs 
maintained in NWKI media (N2B27 media plus 100 µg ml − 1 Wnt3a, 20% KOSR 
and 2 µM IWP2) for five passages were mixed with Matrigel (BD Biosciences) at 
1:1 ratio and transplanted under the kidney capsule of SCID mice. Transplanted 
kidney capsules were collected after 6–8 weeks, fixed in 4% PFA, embedded in 
paraffin, cut to 5 µM section on a microtome and stained with hematoxylin  
and eosin. All procedures were conducted in accordance with the Stanford  
Administrative Panel for Laboratory Animal Care guidelines. 
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